Our 2025 focus is on pipeline
Pfizer CEO Says Activist Wants Minimal Changes, Plays Down Fight
Pfizer Inc.’s dispute with activist firm Starboard Value LP isn’t “an aggressive situation,” Chief Executive Officer Albert Bourla said, months after the feared investor disclosed a stake in the company and questioned his management.
While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...
GlobalData on MSN4d
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...
Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...
Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on.
In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim Cramer recently discussed. In a recent episode of CNBC's Squawk On The Street, Jim ...
11d
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert ...
From condemning the Jan. 6 Capitol riots to helping fund the President-elect’s impending inauguration, recent years have seen ...
4don MSN
Pfizer CEO Albert Bourla said he had spoken to Robert F. Kennedy Jr. in an effort to “find opportunities on things we can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback